Bupa UK has reported that its revenues increased in the first half of 2015, with UK revenue growing 3% to £1,375m, however underlying profit fell 10% to £55.4m, compared to 2014.
Across the Bupa group, revenue increased by 3% to reach £4.9bn while underlying profit decreased 3% at actual exchange rates, to £259.8m for the first half of 2015, compared to the same period in 2014.
At constant exchange rates Bupa's revenue increased 7% and profit rose 2%.
Revenue growth was attributed to growth in SME and corporate private medical insurance (PMI) schemes, while the decline in profit was attributed to the narrowing margins in corporate PMI schemes.
Worldwide Bupa now has 25.3m customers, an increase of 14%, in the UK Bupa has 3.6m customers, an increase of 3%, although individual PMI sales declined.
Bupa Global saw revenue decline 1% at the Constant Exchange rate to £487m, while underlying profit rose 36% to £37.4m, as the number of customers remained flat at 1.9m.
The increase in profit was attributed to re-pricing loss-making corporate accounts,
Bupa's exit of "non-strategic" markets and cost and operations changes.
Stuart Fletcher, CEO of Bupa, said: "We've made steady progress in the first half of 2015, despite a challenging backdrop, delivering revenue and underlying profit growth at CER and maintaining strong market positions underpinned by a robust balance sheet.
"This demonstrates the benefit of our diverse footprint spanning multiple geographies across health insurance and healthcare provision.
"Looking forward, while market conditions remain challenging in a number of our markets, our customer focus, international scale, market leading positions, and strong financial management mean we are positioned to deliver continued revenue and profit growth."
Cheryl Lythgoe shines a light on the medical facts behind the coronavirus myths
Looking ahead to #NoVAD
During to COVID-19
A remote private GP shares his view